Evolution of the Average Target: COMPASS Pathways plc

Evolution of the Target Price: COMPASS Pathways plc

Changes in Analyst Recommendations: COMPASS Pathways plc

ea64f4b862840bd.jgDjYUKTkXJtVGqId2LAAK6pcijL9b7S92CIbn55-ag.-G-hExrD4UYyNgnBHxGUbt7EBmOZofqkwQS9WUs6suPpSrAnEMLnPzggOw~abd4cc29e0d3bea6786c835ec0bcc987
08-06 B. Riley Adjusts COMPASS Pathways Price Target to $22 From $17, Maintains Buy Rating MT
08-06 RBC Adjusts PT on COMPASS Pathways to $21 From $22, Maintains Outperform Speculative Risk Rating MT
07-27 Wells Fargo Initiates COMPASS Pathways at Equalweight MT
07-08 Compass Pathways' COMP360 Data Supports FDA Approval Potential, RBC Says MT
05-14 RBC Raises Price Target on COMPASS Pathways to $22 From $21, Keeps Outperform, Speculative Risk MT
05-04 Jefferies & Co Initiates Coverage on COMPASS Pathways With Buy Rating, $18 Price Target MT
04-24 B. Riley Initiates COMPASS Pathways at Buy With $17 Price Target MT
04-20 Top Midday Gainers MT
02-18 RBC Capital Adjusts Price Target on COMPASS Pathways to $22 From $21, Maintains Outperform Rating MT
01-23 RBC Raises Price Target on COMPASS Pathways to $21 From $16, Keeps Outperform, Speculative Risk MT
11-05 RBC Adjusts Price Target on COMPASS Pathways to $16 From $15, Maintains Outperform Rating MT
25-06-23 Evercore ISI Downgrades COMPASS Pathways to In Line From Outperform MT
25-02-27 Stifel Nicolaus Initiates Coverage on COMPASS Pathways With Buy Rating, $11 Price Target MT
24-11-01 RBC Cuts Price Target on COMPASS Pathways to $18 From $23, Keeps Outperform, Speculative Risk MT
24-07-23 RBC Initiates COMPASS Pathways at Outperform, Speculative Risk With $23 Price Target MT
24-06-05 Morgan Stanley Adjusts COMPASS Pathways Price Target to $23 From $30, Maintains Overweight Rating MT
24-04-01 Morgan Stanley Initiates COMPASS Pathways at Overweight With $30 Price Target MT
23-12-12 Deutsche Bank Initiates Coverage on COMPASS Pathways With Buy Rating, $16 Price Target MT
23-08-22 Canaccord Genuity Cuts Price Target on COMPASS Pathways to $50 From $60, Maintains Buy Rating MT
23-03-01 Citigroup Adjusts Price Target on COMPASS Pathways to $19 From $45, Maintains Buy Rating MT
22-12-16 EF Hutton Initiates COMPASS Pathways at Buy With $38 Price Target MT
22-12-09 Oppenheimer Adjusts COMPASS Pathways Price Target to $33 From $55, Maintains Outperform Rating MT
22-11-21 Berenberg Resumes COMPASS Pathways at Buy With $33 Price Target MT
22-11-01 Loop Capital Initiates COMPASS Pathways at Buy With $34 Price Target MT
22-10-13 Oppenheimer Adjusts COMPASS Pathways Price Target to $55 From $65, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+76.58%
+21.07%
+8.93%
+24.62%
+16.27%
+31.7%
+24.8%
+0.58%
+2.96%
+0.34%
Average +20.78%
Weighted average by Cap. +17.56%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
13.45USD
Average target price
23.75USD
Spread / Average Target
+76.58%
High Price Target
65.00USD
Spread / Highest target
+383.27%
Low Price Target
13.00USD
Spread / Lowest Target
-3.35%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

B. Riley
RBC Capital Markets
Wells Fargo Securities
Jefferies & Co.
Evercore ISI
Stifel Nicolaus
Morgan Stanley
Deutsche Bank Securities
Canaccord Genuity
Citigroup
EF Hutton
Oppenheimer
Berenberg Bank
Loop Capital
HC Wainwright
Cantor Fitzgerald
Roth Capital Partners
Maxim
BTIG
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
13.45USD
Average target price
23.75USD
Spread / Average Target
+76.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock
  4. Consensus COMPASS Pathways plc